Epicyte Pharmaceuticals
Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Epicyte Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.